메뉴 건너뛰기




Volumn 5, Issue 1, 2005, Pages 19-22

Adverse drug interactions

Author keywords

Cytochrome P450; Drug interaction; P glycoprotein

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CIMETIDINE; CIPROFLOXACIN; CYCLOSPORIN; CYTOCHROME P450 1A2; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 3A4; CYTOCHROME P450 ISOENZYME; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ERYTHROMYCIN; FLUVOXAMINE; GLYCOPROTEIN P; LAMIVUDINE; METRONIDAZOLE; MONOAMINE OXIDASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PHENYTOIN; PROTEINASE INHIBITOR; RIFAMPICIN; THEOPHYLLINE; UNINDEXED DRUG; WARFARIN; ZALCITABINE;

EID: 14644430998     PISSN: 14702118     EISSN: None     Source Type: Journal    
DOI: 10.7861/clinmedicine.5-1-19     Document Type: Review
Times cited : (6)

References (5)
  • 2
    • 3042723720 scopus 로고    scopus 로고
    • Adverse drug reactions as cause of admission to hospital: Prospective analysis of 18,820 patients
    • Pirmohamed M, James S, Meakin S, Green C et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. BMJ 2004;329:15-9.
    • (2004) BMJ , vol.329 , pp. 15-19
    • Pirmohamed, M.1    James, S.2    Meakin, S.3    Green, C.4
  • 3
    • 0030935086 scopus 로고    scopus 로고
    • Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions
    • Review
    • Bertz RJ, Granneman GR. Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions. Review. Clin Pharmacokinet 1997;32: 210-58.
    • (1997) Clin Pharmacokinet , vol.32 , pp. 210-258
    • Bertz, R.J.1    Granneman, G.R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.